Office of Neuroscience - Division of Neurology I
The Division of Neurology I (DNI) regulates and reviews Investigational New Drug (IND) applications and marketing applications for drug and biologic products for the treatment of neurodegenerative disorders, movement disorders, and neuromuscular disorders, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, muscular dystrophy, amyotrophic lateral sclerosis, and spasticity.
Contact Us
Mailing Address
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Neurology (DN I)
10903 New Hampshire Avenue, Silver Spring, MD 20993
Building 22, Suite 4346
Phone: (301) 796-2250
Fax: (301) 796-9842
Resources For You
- Office of Neuroscience
- Office of New Drugs
- CDER Offices and Divisions
- Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality